PUBLICATIONS

MORSE Consulting is pleased to release our Fifth Annual pCPA Year in Review Infographic – 2021 Edition.  This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2021. This infographic compares year-over-year metrics including: pCPA activity summary; addresses backlog of files under consideration; average time to complete a negotiation; and files adjudicated by the pCPA by type. MORSE Consulting’s…

Author: Patrick Manfred, Vice-President, TACT Conseil, Quebec Market Access Expert   Date: June 2, 2021   A proposal to modify the current regulation framing the fees payable to the Institut national d'excellence en santé (INESSS) to complete a scientific evaluation of a drug and/or a stable blood product was published in Part 2 of the Quebec Official Gazette, on March 18, 2021. If the…

MORSE Consulting is pleased to release our Fourth Annual pCPA Year in Review Infographic – 2020 Edition.  This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2020. This infographic compares year-over-year metrics including: pCPA activity summary; the effect of COVID-19 on under-consideration files; average time to complete a negotiation; and files adjudicated by the pCPA by type in…

MORSE Consulting is pleased to release our Third Annual pCPA Year in Review infographic - 2019 Edition.  This resource is aimed at helping market access stakeholders understand the top-line pCPA highlights from 2019. This infographic compares year-over-year metrics including: pCPA activity summary; average time to complete a negotiation; files adjudicated by the pCPA; and average negotiation duration by source. This infographic is an excerpt from the 2019 update…

The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.

Introduction MORSE Consulting is pleased to contribute its pCPA/public payer expertise with leading pricing and reimbursement experts and provide our respective views on how the new PMPRB regulations may impact the Canadian environment.  These experts include: PMPRB: Joan McCormick, Principal Consultant - IQVIA HTA/Health Economics (HE): Sumeet Singh & Heather Cameron – Cornerstone Research Group Inc. Private Payers: Suzanne Lepage, Suzanne Lepage Consulting The…

MORSE Consulting is pleased to release its 2018 pCPA Year in Review infographic.  The purpose of this resource is to help market access professionals provide a top-line pCPA performance summary to both internal and external stakeholders. This infographic compares the negotiation activities of the pCPA in 2018 to 2017 as it relates to: completed negotiations by source (CDR, pCODR, pCPA initiated); a breakdown of…

MORSE Consulting is pleased to release a new report by Stephen Filbey of WestPAR Consulting, one of its strategic partners, entitled A Pharma industry Perspective/Opinion on British Columbia’s 2019 Budget. The NDP Government of BC, under the first non-majority legislature since 1952, has just released its second budget. With a strong economy, balanced operating budget, and an estimated $340 million in surplus over the…

MORSE Consulting is pleased to release a new report entitled Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis. While the majority of Canadians have some form of prescription medication coverage, the speed and extent to which individual patients gain access to new therapies, can vary significantly. As new drugs (and expanded indications for existing drugs) are approved by Health…

Toronto, December 13, 2018 – Neil Grubert and MORSE Consulting are pleased to announce the release of a new report entitled Pharmaceutical Managed Entry Agreements – Lessons Learned from Europe, the United States, Canada, and Australia. A performance or outcomes-based agreement (OBA) tracks the effectiveness of a drug in a defined patient population over a specified period of time and directly links the price…

Executive Brief     The First Nations Health Authority (FNHA), formed in 2013 in the province of British Columbia, is the first province-wide health authority of its kind in Canada. Its objective is the full transferral of programs, services, and responsibilities that were under Health Canada’s First Nations Inuit Health Branch (FNIHB) − Pacific Region’s former jurisdiction. One of the many components of the…

Biosimilar Panel   On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was “Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada” which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE…